EUVIMEDEUVIMED entdecken
Crossref

Clinical significance of the naples prognostic score in patients with colorectal liver metastases

Hiroshi Nakanishi, Mitsuru Yanagaki, Hiroaki Shiba, Yoichi Toyama, Masashi Tsunematsu, Yoshihiro Shirai, Michinori Matsumoto, Tomohiko Taniai, Koichiro Haruki, Kenei Furukawa, Toru Ikegami

Surgery Today · 2025

DOI: 10.1007/s00595-025-03200-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery Today, 2025. Verfasst von Hiroshi Nakanishi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-ku,…. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms, Hepatectomy. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: The prognostic outcome of the Naples prognostic score (NPS) in patients with colorectal liver metastases (CRLMs) who have undergone hepatectomy has not been investigated. The present study investigated the prognostic value of the preoperative NPS score and other systemic inflammation-related biomarkers in patients who underwent hepatectomy for CRLMs. PATIENTS AND METHODS: The subjects included 179 patients with CRLMs who underwent hepatectomy and retrospectively investigated the association of preoperative NPS with the surgical failure-free survival (SFFS), disease-free survival (DFS), and overall survival (OS) using univariate and multivariate analyses. RESULTS: In this study, the cutoff NPS value was 2. In the univariate analysis, a high NPS was associated with a worse SFFS (p = 0.04) and OS (p = 0.02). The multivariate analysis showed significant and independent predictors of the OS were extrahepatic lesions (p < 0.01), serum carcinoembryonic antigen (CEA) levels (p = 0.04), and a high NPS (p = 0.04). CONCLUSION: The NPS can be useful in predicting long-term outcomes in patients with CRLMs after hepatectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsColorectal NeoplasmsHepatectomyHumansMalePrognosisFemaleMiddle AgedAgedRetrospective StudiesCarcinoembryonic AntigenBiomarkers, TumorDisease-Free SurvivalSurvival RateAdultMultivariate AnalysisAged, 80 and overClinical Relevance

Stichwörter der Autor:innen

Colorectal liver metastasisInflammation-related scoring systemsNaples prognostic score

Substanzen

Carcinoembryonic AntigenBiomarkers, Tumor

Autor:innen und Institutionen

  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo, 105-8461, Japan.
  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo, 105-8461, Japan. myanagaki@jikei.ac.jp.

Zitieren

APA

Nakanishi, H., Yanagaki, M., Shiba, H., Toyama, Y., Tsunematsu, M., Shirai, Y., Matsumoto, M., Taniai, T., Haruki, K., Furukawa, K., & Ikegami, T. (2025). Clinical significance of the naples prognostic score in patients with colorectal liver metastases. Surgery Today. https://doi.org/10.1007/s00595-025-03200-0

Vancouver

Nakanishi H, Yanagaki M, Shiba H, Toyama Y, Tsunematsu M, Shirai Y, et al. Clinical significance of the naples prognostic score in patients with colorectal liver metastases. Surgery Today. 2025. doi:10.1007/s00595-025-03200-0

BibTeX
@article{Nakanishi2025,
  author = {Nakanishi, Hiroshi and Yanagaki, Mitsuru and Shiba, Hiroaki and Toyama, Yoichi and Tsunematsu, Masashi and Shirai, Yoshihiro and Matsumoto, Michinori and Taniai, Tomohiko and Haruki, Koichiro and Furukawa, Kenei and Ikegami, Toru},
  title = {Clinical significance of the naples prognostic score in patients with colorectal liver metastases},
  journal = {Surgery Today},
  year = {2025},
  doi = {10.1007/s00595-025-03200-0}
}
Kostenlos starten →